81 related articles for article (PubMed ID: 16290002)
1. The prevalence of HR-HPV DNA in ASC-US Pap smears: A military population study.
Stany MP; Bidus MA; Reed EJ; Kaplan KJ; McHale MT; Rose GS; Elkas JC
Gynecol Oncol; 2006 Apr; 101(1):82-5. PubMed ID: 16290002
[TBL] [Abstract][Full Text] [Related]
2. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
Bansal M; Austin RM; Zhao C
Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
[TBL] [Abstract][Full Text] [Related]
3. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
4. Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents.
Boardman LA; Stanko C; Weitzen S; Sung CJ
Obstet Gynecol; 2005 Apr; 105(4):741-6. PubMed ID: 15802399
[TBL] [Abstract][Full Text] [Related]
5. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
Johnston EI; Logani S
Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
[TBL] [Abstract][Full Text] [Related]
6. Atypical parakeratotic spires and HCII HPV results: correlation in liquid-based cervicovaginal cytology specimens interpreted as ASC-US.
Kubba LA; Patel K; Du H; Hahn EA; Sturgis CD
Diagn Cytopathol; 2007 Aug; 35(8):476-81. PubMed ID: 17636491
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HPV types in a cohort of Greeks with clinical indication of infection.
Yapijakis C; Adamopoulou M; Antonopoulos G; Koufaliotis N; Vairaktaris E
Anticancer Res; 2008; 28(4B):2233-7. PubMed ID: 18751400
[TBL] [Abstract][Full Text] [Related]
8. The HPV DNA virus hybrid capture assay: what is it--and where do we go from here?
Vernick JP; Steigman CK
MLO Med Lab Obs; 2003 Mar; 35(3):8-10, 13; quiz 14-5. PubMed ID: 12685257
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HPV-DNA in Pap smears containing ASC and AGC performed within Population Programme of Prophylaxis and Early Detection of Early Cervical Cancer.
Ludwin A; Ludwin I; Pityński K; Jach R; Banaś T; Stangel-Wojcikiewicz K; Horbaczewska A; Pietrus M
Przegl Lek; 2012; 69(11):1189-93. PubMed ID: 23646445
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
12. Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35?
Baay MF; Tjalma WA; Lambrechts HA; Pattyn GG; Lardon F; Weyler J; Van Royen P; Van Marck EA; Vermorken JB
Eur J Cancer; 2005 Nov; 41(17):2704-8. PubMed ID: 16242316
[TBL] [Abstract][Full Text] [Related]
13. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area.
Núñez-Troconis J; Delgado M; González J; Mindiola R; Velásquez J; Conde B; Whitby D; Munroe DJ
Invest Clin; 2009 Jun; 50(2):203-12. PubMed ID: 19662815
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
16. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia.
Stevens MP; Garland SM; Tan JH; Quinn MA; Petersen RW; Tabrizi SN
J Med Virol; 2009 Jul; 81(7):1283-91. PubMed ID: 19475612
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of abnormal cervical cytology in a sexually transmitted diseases clinic.
Kanno MB; Nguyen RH; Lee EM; Zenilman JM; Erbelding EJ
Int J STD AIDS; 2005 Aug; 16(8):549-52. PubMed ID: 16105189
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.
Panotopoulou E; Tserkezoglou A; Kouvousi M; Tsiaousi I; Chatzieleftheriou G; Daskalopoulou D; Magiakos G
J Med Virol; 2007 Dec; 79(12):1898-905. PubMed ID: 17935171
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus infection prior to coitarche.
Doerfler D; Bernhaus A; Kottmel A; Sam C; Koelle D; Joura EA
Am J Obstet Gynecol; 2009 May; 200(5):487.e1-5. PubMed ID: 19268884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
